N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide – (439081-18-2)

niflumic acid, 4394-00-7, Landruma, Nifluril, Forenol, Acido niflumico, Nifluminic acid, Acide niflumique, Niflugel, 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid, UP 83, Acide niflumique [INN-French], Acido niflumico [INN-Spanish], Acidum niflumicum [INN-Latin], Acidum niflumicum, Acide niflumique [French], Acido niflumico [Italian], Niflamol, 2-(3-(Trifluoromethyl)anilino)nicotinic acid, 2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid, 2-[3-(Trifluoromethyl)anilino]nicotinic acid, Niflugel (TN), 3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-, 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid, 2-(3-Trifluoromethylanilino)nicotinic Acid, 2-((3-(Trifluoromethyl)phenyl)amino)nicotinic acid, Niflumic acid (INN), CCRIS 5740, SC 1332, Lopac-N-0630, Actol, analgesic, EINECS 224-516-2, 4U5MP5IUD8, MFCD00010569, NSC-758196, BRN 0489360, Niflumic acid [INN:BAN:DCF], DTXSID1023368, UP-83, 2-(alpha, alpha, alpha-Trifluoro-m-toluidino)nicotinic acid, 2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID, Aza-2 dimethyl-2', 3' (tetrazolyl-5)-6 diphenylamino [French], 3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-, NIFLUMIC ACID [MI], 2-[(3-TRIFLUOROMETHYL)PHENYL]AMINO-3-PYRIDINE-CARBOXYLIC ACID, NIFLUMIC ACID [INN], Aza-2 dimethyl-2', 3' (tetrazolyl-5)-6 diphenylamino, MLS000069713, NIFLUMIC ACID [MART.], DTXCID903368, NIFLUMIC ACID [WHO-DD], NFL, CHEBI:34888, 2-(3-(Trifluoromethyl)phenylamino)nicotinic acid, 5-22-13-00598 (Beilstein Handbook Reference), NIFLUMIC ACID [EP IMPURITY], NIFLUMIC ACID [EP MONOGRAPH], Niflumic Acid-d5, NSC 758196, NCGC00015724-10, Nicotinic acid, 2-(alpha, alpha, alpha-trifluoro-m-toluidino)-, Niflumate, SMR000058199, CAS-4394-00-7, Nicotinic acid, 2-(.alpha., .alpha., .alpha.-trifluoro-m-toluidino)-, 2-(3-[Trifluoromethyl]anilino)nicotinic acid, Acid, Niflumic, NIFLUMIC ACID (MART.), Niflumic Acid-d5 (Major), Acide niflumique (INN-French), Acido niflumico (INN-Spanish), Acidum niflumicum (INN-Latin), 2-[3-(Trifluoromethyl)anilino]-3-pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid, NIFLUMIC ACID (EP IMPURITY), NIFLUMIC ACID (EP MONOGRAPH), 1794811-58-7, SR-01000000231, 2-(3-Trifluoromethyl-phenylamino)-nicotinic acid, UNII-4U5MP5IUD8, 2-(3-(Trifluoromethyl)anilino)-3-pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid, niflumic-acid, ni-flumic acid, Prestwick_890, Spectrum_001353, 1td7, 2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid, Opera_ID_1746, Prestwick0_000255, Prestwick1_000255, Prestwick2_000255, Prestwick3_000255, Spectrum2_000794, Spectrum3_001485, Spectrum4_000043, Spectrum5_001216, Niflumic acid (Standard), Niflumic acid (Hit 16), N 0630, 2-[(3-Trifluoromethylphenyl)amino]nicotinic Acid, CBiol_001828, Lopac0_000845, SCHEMBL24706, BSPBio_000070, BSPBio_001393, BSPBio_003069, KBioGR_000113, KBioGR_000505, KBioSS_000113, KBioSS_001833, MLS001076327, CHEMBL63323, DivK1c_000277, SPECTRUM1502015, SPBio_000928, SPBio_002289, BPBio1_000078, GTPL2439, BDBM85507, HMS500N19, HY-B0493R, KBio1_000277, KBio2_000113, KBio2_001833, KBio2_002681, KBio2_004401, KBio2_005249, KBio2_006969, KBio3_000225, KBio3_000226, KBio3_002569, M01AX02, M02AA17, NINDS_000277, 2-[(3-Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid, Bio1_000114, Bio1_000603, Bio1_001092, Bio2_000113, Bio2_000593, HMS1361F15, HMS1568D12, HMS1791F15, HMS1921D12, HMS1989F15, HMS2090D19, HMS2095D12, HMS2234F11, HMS3262J11, HMS3374H01, HMS3402F15, HMS3649A08, HMS3656P14, HMS3712D12, HMS3885I03, Pharmakon1600-01502015, HY-B0493, NSC_4488, UWC81158, Tox21_110206, Tox21_500845, BBL003619, CCG-40157, DL-457, NSC758196, s3018, STK803109, AKOS000519590, Tox21_110206_1, AC-2652, DB04552, FN26214, GS-3202, LP00845, SDCCGSBI-0050821.P004, IDI1_000277, IDI1_033863, NCGC00015724-01, NCGC00015724-02, NCGC00015724-03, NCGC00015724-04, NCGC00015724-05, NCGC00015724-06, NCGC00015724-07, NCGC00015724-08, NCGC00015724-09, NCGC00015724-11, NCGC00015724-12, NCGC00015724-13, NCGC00015724-14, NCGC00015724-17, NCGC00015724-29, NCGC00023636-03, NCGC00023636-04, NCGC00023636-05, NCGC00023636-06, NCGC00023636-07, NCGC00023636-08, NCGC00023636-09, NCGC00261530-01, SY002411, CAS_4394-00-7, SBI-0050821.P003, 2(3'-trifluormethylanilino)-nicotinic acid, AB00052255, EU-0100845, NS00010059, SW197011-3, T2353, EN300-17360, D08275, H10042, M02156, AB00052255-17, AB00052255_18, AB00052255_19, 2-((3-(Trifluoromethyl)phenyl)amino)nicotinicacid, Q304285, SR-01000000231-2, SR-01000000231-5, SR-01000000231-6, BRD-K98763141-001-04-3, BRD-K98763141-001-06-8, BRD-K98763141-001-17-5, BRD-K98763141-001-29-0, BRD-K98763141-001-30-8, SR-01000000231-11, Z56922127, Niflumic acid, European Pharmacopoeia (EP) Reference Standard, 224-516-2